CompletedNot Applicable

Echocardiography as Risk-Assessment for Major Adverse Cardiac Events in Major Vascular Surgery Patients

813 participantsStarted 2011-01-01

Plain-language summary

Patient with coronary artery disease (CAD), heart failure and abnormal heart function undergoing major vascular surgery have a high associated high morbidity and mortality with myocardial infarction accounting for 33-50% of perioperative deaths. The prevalence of CAD in vascular surgery patients approaches 50%. Proper pre-procedure protocols to accurately assess patients and determine who may require further medical optimization prior to undergoing surgery help mitigate risk and improve outcomes. The investigators designed this study as a single center, retrospective cohort analysis to explore the association between ventricular (LV and RV function) and valvular (Aortic / Mitral / Tricuspid) function and expanded major adverse cardiac events (X-MACE).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Major vascular surgery operation (e.g. CEA, open aortic repair, suprainguinal and infrainguinal bypasses, EVAR, TEVAR) captured in the UVA Vascular Quality Initiative database * Echocardiography within two years of index operation Exclusion Criteria: * If patient had additional qualifying vascular procedure within 30 days of the index operation, this procedure was excluded

What they're measuring

Expanded Major Adverse Cardiac Events

Timeframe: In-hospital admission (within 120 days of index surgery)

Trial details

NCT IDNCT04836702

SponsorUniversity of Virginia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-06-23

View on ClinicalTrials.gov More Left-Sided Heart Failure trials